These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8888118)
21. Niacin-respondent subset of schizophrenia – a therapeutic review. Xu XJ; Jiang GS Eur Rev Med Pharmacol Sci; 2015; 19(6):988-97. PubMed ID: 25855923 [TBL] [Abstract][Full Text] [Related]
22. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Hudson CJ; Young LT; Li PP; Warsh JJ Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811 [TBL] [Abstract][Full Text] [Related]
23. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Puri BK; Hirsch SR; Easton T; Richardson AJ Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):49-52. PubMed ID: 11853118 [TBL] [Abstract][Full Text] [Related]
24. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls. Nilsson BM; Hultman CM; Wiesel FA Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583 [TBL] [Abstract][Full Text] [Related]
25. Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update. Bennett CN; Horrobin DF Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):47-59. PubMed ID: 10970713 [TBL] [Abstract][Full Text] [Related]
26. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Fenton WS; Hibbeln J; Knable M Biol Psychiatry; 2000 Jan; 47(1):8-21. PubMed ID: 10650444 [TBL] [Abstract][Full Text] [Related]
27. Normal phospholipid-related signal transduction in autism. Puri BK; Singh I Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1405-7. PubMed ID: 12502030 [TBL] [Abstract][Full Text] [Related]
28. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study. Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133 [TBL] [Abstract][Full Text] [Related]
29. Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia. Deicken RF; Merrin EL; Floyd TC; Weiner MW Schizophr Res; 1995 Jan; 14(2):177-81. PubMed ID: 7710998 [TBL] [Abstract][Full Text] [Related]
30. Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population. Sun L; Yang X; Jiang J; Hu X; Qing Y; Wang D; Yang T; Yang C; Zhang J; Yang P; Wang P; Cai C; Wang J; He L; Wan C Schizophr Bull; 2018 Jun; 44(4):896-907. PubMed ID: 29077970 [TBL] [Abstract][Full Text] [Related]
31. Membrane phospholipids and cytokine interaction in schizophrenia. Yao JK; van Kammen DP Int Rev Neurobiol; 2004; 59():297-326. PubMed ID: 15006493 [TBL] [Abstract][Full Text] [Related]
33. Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062 [TBL] [Abstract][Full Text] [Related]
34. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry. Ross BM; Hughes B; Turenne S; Seeman M; Warsh JJ Eur Neuropsychopharmacol; 2004 May; 14(3):191-7. PubMed ID: 15056478 [TBL] [Abstract][Full Text] [Related]
35. [Diseases of phospholipid metabolism as possible pathogenetic factors in schizophrenia. Current findings and critical evaluation]. Smesny S; Volz HP; Riehemann S; Sauer H Fortschr Neurol Psychiatr; 2000 Jul; 68(7):301-12. PubMed ID: 10945156 [TBL] [Abstract][Full Text] [Related]
36. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Horrobin DF Schizophr Res; 1998 Apr; 30(3):193-208. PubMed ID: 9589514 [TBL] [Abstract][Full Text] [Related]
37. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Corfas G; Roy K; Buxbaum JD Nat Neurosci; 2004 Jun; 7(6):575-80. PubMed ID: 15162166 [TBL] [Abstract][Full Text] [Related]